Re: Surveillance or Metastasis-directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
- PMID: 29680732
- DOI: 10.1016/j.eururo.2018.03.037
Re: Surveillance or Metastasis-directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
Comment on
-
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial.J Clin Oncol. 2018 Feb 10;36(5):446-453. doi: 10.1200/JCO.2017.75.4853. Epub 2017 Dec 14. J Clin Oncol. 2018. PMID: 29240541 Clinical Trial.
Similar articles
-
The role of metastasis-directed therapy and local therapy of the primary tumor in the management of oligometastatic prostate cancer.Investig Clin Urol. 2017 Sep;58(5):307-316. doi: 10.4111/icu.2017.58.5.307. Epub 2017 Aug 8. Investig Clin Urol. 2017. PMID: 28868501 Free PMC article. Review.
-
[Oligometastatic prostate cancer. concept and implications.].Arch Esp Urol. 2018 Mar;71(3):239-246. Arch Esp Urol. 2018. PMID: 29633944 Review. Spanish.
-
Androgen-Deprivation Therapy Is More Than Palliation in Oligometastatic Prostate Cancer.J Clin Oncol. 2018 Aug 1;36(22):2350. doi: 10.1200/JCO.2018.78.0031. Epub 2018 Jun 1. J Clin Oncol. 2018. PMID: 29856689 No abstract available.
-
Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.J Urol. 2005 Jun;173(6):1966-7. doi: 10.1016/s0022-5347(05)60188-7. J Urol. 2005. PMID: 15879791 No abstract available.
-
Recent advances in radiation oncology: multimodal targeting of high risk and recurrent prostate cancer.Curr Opin Oncol. 2018 May;30(3):165-171. doi: 10.1097/CCO.0000000000000440. Curr Opin Oncol. 2018. PMID: 29465428 Review.
Cited by
-
Clinical Effect of Fuzheng Guben Decoction in the Treatment of Localized Prostate Cancer and Its Influence on Immune Function under Continuous Nursing Intervention.Contrast Media Mol Imaging. 2022 Sep 16;2022:3472722. doi: 10.1155/2022/3472722. eCollection 2022. Contrast Media Mol Imaging. 2022. Retraction in: Contrast Media Mol Imaging. 2023 Jul 19;2023:9820320. doi: 10.1155/2023/9820320. PMID: 36185576 Free PMC article. Retracted. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical